Influence of formulation on jet nebulisation quality of α1 protease inhibitor

International Journal of Pharmaceutics

Volumn 178, Issue 1, 1999, Pages 101-109

  Flament, M P ^a   Leterme, P ^a   Burnouf, T ^b   Gayot, A ^a  

^a UNIV LILLE   (France)

^b LFB   (France)

Author keywords

1 Protease inhibitor; Antifoam; Formulation; Nebulisation quality; Surface tension

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIFOAMING AGENT; HEXADECANOL; SORBITAN TRISTEARATE; TYLOXAPOL;

ARTICLE; DRUG QUALITY; NEBULIZATION; NEBULIZER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE TENSION; VISCOSITY;

ANTIFOAMING AGENTS; CHEMISTRY, PHARMACEUTICAL; FATTY ALCOHOLS; HYDROGEN-ION CONCENTRATION; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; PROTEASE INHIBITORS; SURFACE TENSION; TIME FACTORS; VISCOSITY;

EID: 0033044720     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00354-8     Document Type: Article

References (19)

1. Aiache J.M. Les aérosols médicamenteux. Il Farmaco. 28:1973;243-266.
2. Clay M., Pavia D., Newman S., Clarke S. Factors influencing the size distribution of aerosol from jet nebulisers. Thorax. 38:1983;755-759.
3. Clay M., Pavia D., Newman S.P., Lennard Jones T, Clarke S.W. Assessment of jet nebulisers for lung aerosol therapy. Lancet. 38:1983;592-594.
4. Davis S. Physicochemical studies on aerosol solutions for drug delivery I. Water propylene glycol systems. Int. J. Pharm. 1:1978;71-83.
5. Davis, S., Elson, G., Whitmore, 1978. Physicochemical studies on aerosol solutions for drug delivery II. Water propylene glycol systems. Int. J. Pharm. 1, 85-93.
6. 1P1 solution. Int. J. Pharm. 156:1997;211-217.
7. 1 protease inhibitor. Int. J. Pharm. 148:1997;93-101.
8. Mallol, 1993. Particle size distribution for jet nebulizers commonly employed in the pediatric clinical setting. J. Aerosol Med. 6, 213-219.
9. Mc Callion O.N.M. et al. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm. Res. 12:1995;1682-1688.
10. Mc Callion O.N.M., Taylor K.M.G., Thomas M., Taylor A.J. The influence of surface tension on aerosols produced by medical nebulisers. Int. J. Pharm. 129:1996;123-136.
11. Mc Callion O.N.M., Patel M.J. Viscosity effects on nebulisation of aqueous solutions. Int. J. Pharm. 130:1996;245-249.
12. Mercer T. Production and characterisation of aerosols. Arch. Intern. Med. 131:1973;39-50.
13. Moren F. Dosage forms and formulation for drug administration to the respiratory tract. Drug Dev. Ind. Pharm. 13:1987;655-728.
14. Newman S.P., Pellow P.G.D., Clay M.M., Clarke S.W. Evaluation of jet nebulisers for use with gentamicin solution. Thorax. 40:1985;671-676.
15. Newman S.P., Pellow P.G.D., Clarke S.W. Choice of nebulisers and compressors for delivery of carbenicillin aerosol. Eur. J. Resp. Dis. 69:1986;160-168.
16. Newman S.P. et al. Drop sizes from medical atomisers (nebulisers) for drug solutions with different viscosities and surface tensions. At. Spray Technol. 3:1987;1-11.
17. O' Doherty M.J., Miller R.F. Aerosols for therapy and diagnosis. Eur. J. Nucl. Med. 20:1993;1201-1213.
18. Taylor K.M.G., Venthoye G., Chawla A. Pentamidine isethionate delivery from jet nebulisers. Int. J. Pharm. 85:1992;203-208.
19. USP XXIII, 1994. Physical tests/aerosol (601). Pressurized Metered-Dose Inhalers, 1762-1767.